Authors: Meynard, JL Guiguet, M Rachline, A Boukli, N Bollens, D Gentil, C Frottier, J Morand-Joubert, L

Citation: Jl. Meynard et al., Factors predicting response to antiretroviral regimens with a protease inhibitor in HIV-infected subjects, PRESSE MED, 30(1), 2001, pp. 5-10

Authors: Salmon-Ceron, D Mazeron, MC Chaput, S Boukli, N Senechal, R Houhou, N Katlama, C Matheron, S Fillet, AM Gozlan, J Leport, C Jeantils, V Freymuth, F Costagliola, D

Citation: D. Salmon-ceron et al., Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1041-1049

Authors: Anduze-Faris, BM Fillet, AM Gozlan, J Lancar, R Boukli, N Gasnault, J Caumes, E Livartowsky, J Matheron, S Leport, C Salmon, D Costagliola, D Katlama, C

Citation: Bm. Anduze-faris et al., Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients, AIDS, 14(5), 2000, pp. 517-524